← Evidence map

ArticleProstate cancer and prostatic diseases2024

Reply to RE: Should LHRH therapy be continued in patients receiving Abiraterone Acetate?

Carsten-Henning OhlmannPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 36446944